Panel Discussion: Limitations of Humanised & PDX Models

Time: 2:00 pm
day: Day One


  • How can we push these borders to include more supporting immune cells, dendritic cells, NK-cells?
  • Increasing longevity; CD34 humanised hyper immune-deficient mice can increase available study lengths but also increase the cost. Is there a middle ground?
  • Gaining data on persistence of cellular therapies without requiring additional mice